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Abstract
Within the last 15 years, at least 8 different G protein-coupled P2Y receptors have been characterized. These mediate
slow metabotropic effects of nucleotides in neurons as well as non-neural cells, as opposed to the fast ionotropic effects
which are mediated by P2X receptors. One class of effector systems regulated by various G protein-coupled receptors are
voltage-gated and ligand-gated ion channels. This review summarizes the current knowledge about the modulation of
such neuronal ion channels via P2Y receptors. The regulated proteins include voltage-gated Ca
2+ and K
+ channels, as well
as N-methyl-D-aspartate, vanilloid, and P2X receptors, and the regulating entities include most of the known P2Y receptor
subtypes. The functional consequences of the modulation of ion channels by nucleotides acting at pre- or postsynaptic
P2Y receptors are changes in the strength of synaptic transmission. Accordingly, ATP and related nucleotides may act not
only as fast transmitters (via P2X receptors) in the nervous system, but also as neuromodulators (via P2Y receptors).
Hence, nucleotides are as universal transmitters as, for instance, acetylcholine, glutamate, or g-aminobutyric acid.
Introduction
Many functional characteristics of neurons are similar or
even identical to those of other cells, but there is one
fundamental difference: The primary functions of neuronal
cells are to receive, modify, and transmit messages. This
flow of information occurs within one neuron as well as
between neurons. Whether the neuronal communication is
intra- or intercellular, it is always dependent on electrical
activity which is provided by ligand- as well as voltage-
gated ion channels. With respect to electrical properties,
different neurons are by far not equal but rather character-
ized by prototypical synaptic responses that are governed
by the expression of a certain set of ion channels. Even
within one nerve cell, the electrical properties are not
fixed, but may change with time depending on the presence
of neurotransmitters, hormones, or growth factors. The
basis for changes in the electrical responsiveness of a
neuron are alterations in the opening and closure of ion
channels. Such changes are in many cases triggered by
neurotransmitters that act via heptahelical transmembrane
receptors typically linked to heterotrimeric G proteins [1].
Adenine and uridine nucleotides are present in all types
of cells and are released in response to various stimuli [2].
Once in the extracellular space, they activate one or more
of at least 15 different membrane proteins which are
categorized as P2 receptors. Alternatively, they are
converted to other nucleotides or degraded down to
nucleosides by different ectoenzymes [3]. The receptors
for nucleosides are categorized as P1 receptors. Receptors
for nucleotides comprise ionotropic P2X and metabotropic
P2Y receptors. P2X receptors are ATP-gated cation
channels composed of presumably three subunits out of a
repertoire of at least seven different proteins which all have
two presumed transmembrane domains with large extra-
cellular loops and intracellular N- and C-termini [4, 5].
P2Y receptors, in contrast, are characterized by seven
putative transmembrane domains typical of G protein-
coupled receptors. Currently, at least eight different
subtypes have been identified (P2Y1, 2, 4, 6, 11, 12, 13, 14;
[4, 6–8]. Thus, with respect to the modulation of ion
channels, receptors for nucleotides may represent the
regulated entity in the case of P2X receptors, and they
may also be the regulating entity in the case of P2Y
receptors. This review focuses on the interactions between
P2Y receptors and both, ligand- as well as voltage-gated,
ion channels and therefore deals with P2X receptors in
only a very few instances.
Pharmacological and functional characteristics
of P2Y receptors
A considerable number of heptahelical receptors that can
be activated by extracellular nucleotides have been
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classification of P2 receptors they were categorized as
P2Y receptors and numbered in chronologic order which
led to the description of P2Y1 through P2Y15 receptors
[9]. However, some of the receptors provided with P2Y
receptor numbers were subsequently identified as species
homologues of other P2Y receptors or as members of other
families of G protein-coupled receptors [6]. The presumed
P2Y15 receptor is also activated by a-ketoglutarate [10]
and may thus not be a true member of the P2Y family.
Accordingly, only eight different mammalian subtypes are
currently viewed as members of the P2Y family, namely
P2Y1, 2, 4, 6, 11, 12, 13, 14 [4, 6–8].
These P2Y receptors are activated not only by ATP, but
also by other naturally occurring nucleotides or nucleotide
sugars, such as ADP, UTP, UDP, and UDP glucose [4, 6–8].
At P2Y1 receptors of various species, the rank order of
agonist potency is 2-MeSADPQ2-MeSATP9ADPQATP
with uridine nucleotides being inactive. At P2Y2 receptors,
ATP and UTP are equipotent agonists, and ADP, UDP, or
2-methylthio derivatives have weak or no activity. P2Y4
receptors are activated by UTP, and the rat and mouse
receptors are also activated by ATP, whereas the human
receptors are antagonized by ATP [11]. At P2Y6 receptors,
UDP is the most potent agonist and ADP, ATP or UTP are,
if at all, only weak agonists. Human P2Y11 receptors
show the following rank order of agonist potency: ATPQ
2-MeSATP9ADP, and the observed agonistic activity of
UTP depends on the signalling cascade that is activated by
the receptor [12]. The nucleotide selectivity of canine
P2Y11 receptors is 2-MeSATP9ADP9ATP [13]. At P2Y12
receptors, 2-MesADP is much more potent as an agonist
than ADP, and the efficacy of ATP is species-dependent
with high intrinsic activity at rat but not at human receptors
[14, 15]. P2Y13 receptors are activated by 2-MesADP, ADP,
and ATP, but the rank order of agonist potency is different
for human, murine, and rat receptors [16–18]. The P2Y14
receptor is activated by various UDP sugars, but not by
adenine or uridine nucleotides [8, 19].
According to the agonist profiles summarized above,
P2Y receptors can be characterized as receptors for purines
(P2Y1, 11, 12, 13), for pyrimidines (P2Y6, 14), or for both
types of nucleotides (P2Y2, 4). In parallel, these receptors
can be classified as receptors preferring nucleoside tri-
(P2Y2, 4, 11) or diphosphates (P2Y1, 6, 12, 13, 14). This latter
categorization appears particularly important from a func-
tional point of view, as extracellular nucleotides are
released from a large variety of cells and rapidly converted
by ectoenzymes [3]. The interconversion between different
extracellular nucleotides is also a factor that needs to be
taken into consideration, when P2Y receptors are charac-
terized by the application of various nucleotides. For
instance, the triphosphate sensitivity of P2Y2 and 4
receptors can only be demonstrated unequivocally, if the
conversion of nucleoside diphosphates to triphosphates is
prevented [20]. Given these experimental difficulties with
endogenous and exogenous agonistic nucleotides, the
characterization of P2Y receptors should preferably rely
on the use of specific antagonists. A considerable number
of compounds have been found to block P2Y receptors, but
unfortunately the majority of antagonists is not sufficiently
selective. For instance, the most widely used P2 receptor
antagonists suramin and reactive blue 2 block not only a
large number of P2X and P2Y receptors, but also unrelated
receptors, such as NMDA receptors [21] and anion
channels [22]. Nevertheless, for some P2Y receptor
subtypes selective antagonists have been identified or
developed. For instance, adenosine-2S-phosphate-5S-phos-
phate (A2P5P) and adenosine-3S-phosphate-5S-phosphate
(A3P5P) were found to be partial agonists with low
intrinsic activity at P2Y1 receptors [23]. Derivatives
thereof, such as N
6-methyldeoxyadenosine 3S,5S-biphos-
phate (MRS2179) or 2-chloro-N
6-methyldeoxyadenosine
3S,5S-biphosphate (MRS 2216) are selective and competi-
tive antagonist at P2Y1 receptors with nanomolar affinity
[24]. The P2Y12 receptor has been identified as the target
of metabolites of the well-known antithrombotic drugs
ticlopidine and clopidogrel [25]. ATP derivatives, such as
AR-C69931MX, are also antagonists with high affinity at
this receptor subtype and were developed for clinical use in
patients with acute coronary syndromes [26]. Unfortunate-
ly, this latter agent is not absolutely selective for P2Y12,
but also blocks P2Y13 receptors. However, at P2Y12 this
agent is a competitive, and at P2Y13 a non-competitive,
antagonist [17]. Recently, insurmountable antagonists with
nanomolar affinities for P2Y6 receptors, but no activity at
P2Y1,2,4 and P2Y11 receptors, such as 1,4-di-[(3-isothio-
cyanato phenyl)-thioureido]butane (MRS 2578), have been
developed [27].
P2Y1, 2, 6, 13, and P2Y14 are widely expressed in a
variety of tissues including the nervous system, whereas
P2Y4 and 11 show a restricted expression pattern that
excludes neuronal tissues [4, 9, 19, 28]. P2Y1 mRNA and
protein is found at high levels in many regions of the
central nervous system including the cerebral and cerebel-
lar cortices, hippocampus, caudate nucleus, putamen,
globus pallidus and midbrain [29–31]. In in situ hybrid-
izations of brain sections, the expression pattern of P2Y12
was consistent with a predominantly glial localization
[25, 32]. P2Y13 mRNA was also detected in different brain
regions, such as the thalamus, caudate nucleus, substantia
nigra, hippocampus and cerebellum [28].
In heterologous expression systems, all P2Y receptor
subtypes were found to mediate increases in inositol phos-
phates (IPs) or in intracellular Ca
2+, thus indicating that
they are coupled to phospholipase C (PLC) [4, 9, 28, 32].
The P2Y receptor-mediated increases in IPs did not involve
pertussis toxin-sensitive G proteins in the cases of P2Y1, 6
and 11, but were to various degrees reduced by that
bacterial toxin in the cases of P2Y2 and P2Y4 [4]. With
P2Y12, 13 and P2Y14 receptors, nucleotide-dependent
increases in IPs were only detected when the receptors
were co-expressed together with either Ga16 or chimaeric
G protein a subunits, and the actions mediated by these
receptors were pertussis toxin-sensitive and thus mediated
by inhibitory G proteins [19, 28]. P2Y11 mediates increases
in cyclic AMP in addition to the rises in IPs [9, 33], and the
coupling of this receptor to different effector systems
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P2Y13 mediate a pertussis toxin-sensitive inhibition of ade-
nylyl cyclase [25, 28], and in pertussis toxin-treated cells,
P2Y13 mediates a stimulation of adenylyl cyclase [28].
Regulation of neuronal ion channels via
G protein-coupled receptors
Ion channels and G protein-coupled receptors of neurons
are encoded by several hundred genes, and the list is still
growing. Accordingly, it is impossible to summarize all the
interactions between them, and this chapter highlights only
a few examples which are important for the understanding
of mechanisms that may link P2Y receptors to various ion
channels. The ion channels that will be described below
include ligand-gated ion channels as well as voltage-gated
Na
+,C a
2+ and K
+ channels.
Currently, at least nine different types of pore forming
subunits of voltage-gated Na
+ channels are known and they
contain several sites that may become phosphorylated by
protein kinases A and C. On a functional level, phosphor-
ylation by both kinases leads to reduced Na
+ currents [34].
In accordance with this, D1-like receptors were found to
reduce Na
+ currents in hippocampal neurons via protein
kinase A [35], and this effect was enhanced at hyper-
polarized membrane potentials and by co-activation of
protein kinase C [36]. Moreover, activation of muscarinic
receptors reduced Na
+ currents via protein kinase C in
hippocampal [37] and neocortical neurons [38]. A similar
effect was observed in neurons of the prefrontal cortex
when 5-HT2 receptors were activated [39]. In sensory
neurons, however, hyperalgesic agents increase currents
through tetrodotoxin-resistant Na
+ channels [40], and this
effect was again mediated by protein kinase A [41]. Thus,
several types of G protein-coupled receptors were found to
modulate Na
+ channels and increases as well as decreases
in currents were observed depending on the types of
neurons that were investigated.
Voltage-activated Ca
2+ channels are classified by the
genes encoding the pore forming a1 subunits, and one can
discern between three subfamilies named CaV1t oC a V3.
Members of all three families contribute to the voltage-
gated Ca
2+ currents found in neurons. Channels formed by
CaV1 proteins mediate L-type currents, those containing,
CaV2.1 to CaV2.3 mediate P/Q-, N- and R-type currents,
and those harbouring CaV3 subunits mediate T-type Ca
2+
currents [42]. While channels providing N- and P/Q-type
currents are involved in excitation secretion coupling in
most nerve terminals, the other channels are rather found at
somatodendritic regions of neurons [42]. Modulation via G
protein-coupled receptors has been described for an
exhaustive number of neurotransmitters and for all types
of voltage-gated Ca
2+ currents [43–46]. The modulation of
L-type currents is either facilitatory or inhibitory and is in
most cases mediated by diffusible second messengers and
protein kinases [45]. In contrast, the modulation of N and
P/Q-type channels is almost exclusively inhibitory and is
frequently independent of diffusible second messengers
and protein kinases [43, 44], although there are some
exceptions to this rule [47, 48]. The pathway that excludes
diffusible second messengers is membrane-delimited and
leads to a voltage-dependent inhibition of currents as
revealed by the fact that large depolarisations attenuate
the inhibition. This inhibition is in most, but not all, cases
abolished by pertussis toxin [43], and is based on a direct
interaction between G protein bg subunits and Ca
2+
channel proteins [44, 46]. Pathways involving the synthesis
of diffusible second messengers most commonly lead to a
voltage-independent reduction of Ca
2+ currents and have
been reported to involve a subunits of the Gq/11 protein
family [49, 50].
The superfamily of voltage-dependent K
+ channels
comprises many more members than those of Na
+ or
Ca
2+ channels, and the K
+ channels are, in addition, very
heterogeneous [51]. Although quite a number of these
various K
+ channels were reported to be modulated by
neurotransmitters, the most intensively studied examples of
K
+ channel regulation via G protein-coupled receptors are
inward rectifier (Kir) channels and KCNQ channels which
are now classified as KV7 family [51]. In a variety of
neurons, several neurotransmitters were found to cause
hyperpolarizations by activating inwardly rectifying K
+
currents via receptors coupled to pertussis toxin-sensitive
G proteins. These effects were found to involve proteins of
the Kir3 family and G protein bg subunits [52]. However,
the regulation of G protein-coupled inwardly rectifying K
+
(GIRK) channels depends not only on bg subunits, but also
on other proteins and second messengers. G Protein a sub-
units may act as donors for bg, on one hand, and directly
block GIRK channels [53], on the other hand. Furthermore,
the kinetics of the gating of GIRKs is determined by all
three parameters, receptor type, G protein a, and G protein
bg subunits [54]. In addition, regulators of G protein
signalling also determine the kinetics of GIRK activation
[55]. Moreover, GIRK channels are activated by phospha-
tidylinositol 4,5-bisphosphate (PIP2) [56], and the levels of
PIP2 are also regulated via G protein-coupled receptors and
PLC [57]. As a consequence, activation of receptors linked
to Gq proteins may also contribute to the regulation of
GIRK channels [58]. Finally, activation of Gs coupled
receptors was reported to enhance currents through GIRK
channels [59].
A number of neurotransmitters were found to depolarize
neurons by reducing M-type K
+ currents (IM) which are
believed to be mediated by KCNQ channels [60]. These
ion channels are opened in the subthreshold voltage range
for action potentials and become completely activated
when neurons are further depolarized. Hence, activated
KCNQ channels keep neurons polarized, and closure of
these ion channels causes depolarization and increased
action potential discharge [61, 62]. The inhibition of IM via
M1 muscarinic acetylcholine receptors involves aq subunits
of heterotrimeric GTP binding proteins [63], and a
reduction in PIP2 through an activation of phospholipase
C [64]. The inhibition of IM via bradykinin B2 receptors, in
contrast, involves G proteins of the Gq family, most likely
G11, and rather a then bg subunits [50, 63, 65]. Via these
P2Y receptors and ion channels 33G proteins, phospholipase C-b4 is stimulated [66] to
mediate the synthesis of IP3, which then causes liberation
of Ca
2+ from intracellular stores [67]. Cytosolic Ca
2+
concentrations in the sub- to low micromolar range directly
block KM channels [68].
The nicotinic acetylcholine receptor as a prototypical
ligand-gated ion channel has been shown to be modulated
via a variety of G protein-coupled receptors, and receptor
activation was found to either enhance or reduce the
function of that ion channel [69–73]. The inhibition of
currents through nicotinic acetylcholine receptor was
suggested to be mediated by an inhibition of proteinkinase
A-dependent phosphorylation [73]. The enhancement of
these currents involved pertussis toxin-sensitive G proteins,
but not altered phosphorylation [72]. A direct interaction
between G protein subunits and ligand-gated ion channels
has been demonstrated for glycine receptors. Currents
through these ion channels were enhanced by free G protein
bg subunits [74]. Like nicotinic acetylcholine receptors,
glycine receptors were found to be inhibited by prostaglan-
din E2, and this effect involves proteinkinase A-mediated
phosphorylation [75]. Another ligand-gated ion channel, the
glutamatergic NMDA receptor, is also regulated by phos-
phorylation secondary to the activation of G protein-
coupled receptors. In that case, the activation of muscarinic
acetylcholine receptors enhanced NMDA receptor currents
via protein kinase C and non-receptor tyrosine kinase [76].
However, D2-like receptors reduce currents through NMDA
receptors via transactivation of receptor tyrosine kinases
[77]. In addition, D1 receptors may also directly interact
with NMDA receptors [78]. For the inhibitory transmitter
GABA, a direct interaction of the ionotropic GABAA
receptors and the metabotropic GABAB receptor has been
reported to regulate receptor trafficking [79]. Hence, a
multitude of mechanisms provide functional links between
G protein-coupled receptors and various ligand-gated ion
channels.
Regulation of Na
+ + + + channels via P2Y receptors
ATP was found to enhance or inhibit tetrodotoxin-sensitive
as well as -insensitive voltage-gated sodium channels in rat
dorsal root ganglion neurons [80] and in a neuronal
hippocampal cell line [81]. However, these effects did not
appear to involve G proteins and were rather mediated by a
direct interaction of ATP with the sodium channel. No
additional evidence for a modulation of neuronal Na
+
channels via P2Y receptor could be found in the literature.
Regulation of Ca
2+ + + + channels via P2Y receptors
Native receptors
Since Dunlap and Fischbach [82, 83] first described
transmitter-induced inhibition of voltage-gated calcium
channels, a plethora of other neurotransmitters and hor-
mones that exert their actions via G protein-coupled
receptors have been shown to inhibit native Ca
2+ currents
(see above). First direct evidence for a nucleotide regula-
tion of voltage-gated calcium channels was presented by
Diverse-Pierluissi et al. [84], who showed that ATP and
ADP, but not UTP, induce a pertussis toxin-sensitive
inhibition of voltage-gated Ca
2+ currents in bovine adrenal
chromaffin cells. Subsequent studies by several other
groups [85–87] corroborated these results, and further
showed that this reduction of calcium current amplitudes
was voltage-dependent, antagonized by reactive blue 2 and
due to an inhibition of N- and P/Q-type calcium channels.
Similar results were obtained in rat adrenal chromaffin
cells, where ATP also inhibited voltage-gated Ca
2+
currents in a PTX-sensitive manner and this effect was
also antagonized by reactive blue 2 [88]. Another ATP-
induced inhibition of Ca
2+ currents, which was PTX-
insensitive and voltage-dependent, was observed in frog
sympathetic neurons [89]. In NG108-15 mouse neuroblas-
toma  rat glioma cells, not only adenine nucleotides, but
also UTP and UDP, inhibited whole-cell Ca
2+ currents
[90], with the uridine nucleotides being even more potent
agonists than the adenine nucleotides. In this case, not only
an inhibition of N-type channels was responsible for the
reduction of voltage-gated Ca
2+ currents, but also L-type
calcium channels were inhibited. Interestingly, only the
N-type channel inhibition was PTX-sensitive, while currents
through L-type channels were still modulated after PTX
treatment. However, it remained unclear whether these two
effects were mediated by two different receptor subtypes or
by a single receptor that coupled to multiple G proteins.
More recently, several other examples for Ca
2+ channel
modulation via endogenous P2Y receptors were reported.
Vartian and Boehm [91] found that adenosine nucleotides
inhibited voltage-gated Ca
2+ currents in PC12 cells via a
voltage-dependent and PTX-sensitive mechanism, but at
that time the pharmacological profile of the receptor
involved did not correspond to any of the known P2Y
receptors. However, in subsequent studies the receptor
responsible for this inhibition of voltage-gated Ca
2+
currents in PC12 cells could be identified as the P2Y12
receptor [92, 93]. In hamster submandibular neurons, the
P2Y2 receptor was shown to mediate a voltage-dependent
and PTX-sensitive inhibition of voltage-gated Ca
2+ currents
[94]. Moreover, P2Y1 receptors in rat dorsal root ganglion
neurons [95] and P2Y12 receptors in rat sympathetic
neurons [96] were both shown to mediate a voltage-
dependent and pertussis toxin-sensitive inhibition of N-type
calcium channels.
However, not only inhibitory effects of nucleotides on
Ca
2+ channels have been observed. ATP has also been
shown to increase calcium currents in rat cardiac cells [97]
and in hippocampal neurons [98]. Unfortunately, the
signalling cascades involved in these effects have not been
elucidated in detail.
Recombinant receptors
Based on their findings that UTP activates pertussis toxin-
sensitive as well as -resistant pathways in NG108-15
34 S.G. Lechner & S. Boehmneuronal hybrid cells [90, 99], Alexander Filippov, Eric
Barnard, David Brown and collaborators extended their
investigations on the coupling of P2Y receptors to neuronal
ion channels by using rat superior cervical ganglion
neurons as an expression system for molecularly defined
receptor subtypes. All of the P2Y receptors that were
investigated (P2Y1, 2, 4, 6, 12) did couple to voltage-gated
Ca
2+ channels. As expected for a Gi/o coupled receptor, the
inhibition of voltage-gated Ca
2+ currents by P2Y12 was
voltage-dependent and PTX-sensitive, and thus appeared to
involve only the membrane-delimited pathway [14]. By
contrast, the inhibition of voltage-gated Ca
2+ currents
mediated by P2Y1, 2, 4 and 6 included two components:
(1) the voltage-dependent and PTX-sensitive membrane-
delimited pathway as well as a (2) PTX-resistant compo-
nent. The P2Y2 receptor-mediated inhibition included a
voltage-dependent and PTX-sensitive component, on one
hand, and a voltage-independent and PTX-resistant com-
ponent, on the other hand [100]. By contrast, when P2Y6
[101] or P2Y1 [102, 103] were overexpressed, the pertussis
toxin-resistant component appeared to be voltage-depen-
dent, since it was facilitated by a large depolarizing
prepulse. Interestingly, the authors found that the inhibition
mediated by the P2Y6 receptor is much more pronounced
in perforated patch (73%) as compared to whole-cell (53%)
recordings. Moreover, the inhibition observed in the
perforated-patch configuration was hardly altered by
PTX, while in whole-cell recordings it was reduced by
60% after treatment with this toxin. Similar results were
obtained when P2Y4 receptors were overexpressed [104].
In that case almost no inhibition (õ10%) was observed in
the disrupted whole-cell mode, while currents recorded in
the perforated-patch mode were reduced by õ45% in a
PTX-sensitive and voltage-dependent manner. Taken
together, these findings indicate that even the membrane-
delimited, PTX-sensitive pathway may require a soluble
co-factor, and that a modulation of voltage-gated Ca
2+
currents should rather be investigated in the perforated-
patch than the whole-cell mode of the patch clamp
technique. Unfortunately, most of our current knowledge
concerning the regulation of neuronal Ca
2+ channels via
P2Y and other G protein-coupled receptors stems from
whole-cell experiments only.
Regulation of K
+ + + + channels by P2Y receptors
Native receptors
Besides voltage-gated Ca
2+ channels, a variety of K
+
channels have consistently been shown to be modulated
by nucleotides. One of the first examples was the inhibition
of IM by UTP [105] and ATP [106] in bullfrog sympathetic
neurons. Although the receptors responsible for these
effects remained unknown at that time, the authors could
subsequently show that IM inhibition by nucleotides
involved a G protein [107, 108]. Only a few years later,
after the cloning of the first G protein-coupled nucleotide
receptors, Filippov et al. [99] could demonstrate that
activation of the PLC-linked P2Y2 receptor in NG108-15
neuroblastoma  glioma hybrid cells led to an inhibition of
native IM. Subsequently, several other groups could also
observe an inhibition of IM mediated by native P2Y
receptors. In rat superior cervical ganglion neurons, a
uridine nucleotide preferring receptor, most likely P2Y6,
was reported to mediate an inhibition of IM [109]. The
signalling cascade underlying this inhibition included
activation of PLC, generation of IP3, and release of Ca
2+
from intracellular stores [110]. In rat thoracolumbar
sympathetic neurons [111], UTP and UDP reduced IM in
cultures isolated from 9- to 12-day-old rats, but not in
cultures prepared from newborn animals. More recently,
Meng et al. [112] could show that the nucleotide induced
inhibition of IM in bullfrog sympathetic neurons is
mediated by a P2Y receptor, most likely P2Y4,a s
suggested by the observed rank order of agonist potencies.
In addition to IM modulation, several other neuronal
potassium channels were also found to be modulated by
nucleotides. In a series of papers published in the mid
nineties, Ikeuchi and Nishizaki described an outwardly
rectifying potassium current activated by nucleotides. The
current was found in various regions of the rat brain,
including striatal neurons [113], inferior colliculus neurons
[114], superior colliculus neurons [115], cerebellar neurons
[116] and in hippocampal neurons [117]. Interestingly,
although the current that was induced seemed to be the
same in all these studies, the signal transduction mecha-
nisms, as well as the receptor subtypes involved in channel
activation seemed to differ between the various regions of
the brain that were investigated. Responses that were
induced by ATP in striatal neurons and by adenosine in
superior colliculus and hippocampal neurons involved a
diffusible second messenger and protein kinase C, as could
be shown by single channel recordings from cell-attached
patches and by using the protein kinase C inhibitor
GF109203X, respectively. By contrast, the actions of
ADP in inferior colliculus neurons were membrane
delimited, presumably based on a direct interaction of bg
subunits of a PTX-insensitive G protein with the channel
protein, as could be shown by single channel recordings
from outside-out patches.
In rat hippocampal neurons, ATP was also reported to
inhibit a voltage-gated K
+ channel [118]. UTP was as
potent as ATP, and ADP and a,b-methylene ATP also
inhibited the outward current. More recently, another
voltage-gated potassium channel, a fast delayed inward
rectifier, in Xenopus spinal neurons was found to be
inhibited by adenine and uridine nucleotides [119]. Since
a much larger proportion of the neurons responded to ADP,
but not to ATP or UTP, the authors speculated about the
presence of two different P2Y receptor subtypes, one
mediating the effects of the triphosphates and the other
mediating the effects of ADP.
Recombinant receptors
The potassium channels that have been studied most
extensively with respect to their modulation by heterolo-
P2Y receptors and ion channels 35gously expressed P2Y receptors are the KCNQ channels
and the GIRKs. Among the receptors that were investi-
gated, the Gq/11 coupled receptors P2Y1,2,4 and P2Y6, when
expressed in rat superior cervical ganglion neurons, all
inhibited the IM in a PTX-resistant manner [100, 101, 103,
104]. However, when the P2Y12 receptor was expressed
in these neurons, no inhibition of IM by nucleotides could
be observed [14]. When rat GIRK1 and GIRK2 (Kir3.1
and 3.2 subunits) were co-expressed, 2MeSADP and
2MeSATP, two potent P2Y12 receptor agonists, evoked a
K
+ current through GIRK channels. This is in accordance
with the general concept that Gi/o coupled receptors
mediate an activation of GIRK channels. A more unex-
pected finding was that the Gq/11-linked P2Y1 receptor,
when co-expressed with Kir3.1 and 3.2 subunits instead of
P2Y12, also produced a PTX-sensitive activation of GIRK.
This further supports the idea that a single P2Y receptor
may couple to multiple G proteins. However, with P2Y1,
the fast activation was followed by a slower, but almost
complete inactivation of the current in the continued
presence of the agonist, an effect that has previously been
observed when rat P2Y2 receptors were expressed together
with GIRK1/4 in Xenopus oocytes [120]. Similar results
were also obtained with the mouse P2Y2 receptor, but not
with human P2Y6, when expressed together with GIRK
channels in Xenopus oocytes [121].
Regulation of ligand-gated ion channels by
P2Y receptors
Native receptors
In neurons, nucleotides can act not only on voltage-gated,
but also on ligand-gated ion channels. In layer V
pyramidal neurons of the rat prefrontal cortex, adenine
and uridine nucleotides, presumably acting on P2Y2
receptors, were found to enhance currents elicited by N-
methlyl-D-aspartate (NMDA) [122]. By contrast, ADP-bS,
a potent P2Y1 receptor agonist, inhibited currents through
NMDA receptors [123] in the same cells. Since this
inhibition was antagonized by PPADS and MRS2179, an
involvement of the P2Y1 receptor seemed most likely. In
addition, ATP was found to directly inhibit NMDA
receptors independently of G proteins and, therefore, not
by activation of P2Y receptors. This latter inhibition was
revealed to involve a direct binding of the nucleotide to the
glutamate-binding pocket of the NR2B subunit of NMDA
receptors [124].
Another ligand-gated ion channel that was found to be
modulated by nucleotides is the vanilloid receptor 1 (VR1).
In rat dorsal root ganglion neurons, capsaicin-evoked
currents through VR1 were enhanced by the application
of nucleotides [125]. This nucleotide-induced potentiation
was abolished by application of calphostin C, a potent
protein kinase C inhibitor, and was mimicked by phorbol
esters, thus suggesting that a P2Y receptor linked to protein
kinase C via Gq/11 proteins was involved. Considering the
observed rank order of agonist potencies, the P2Y1 receptor
was considered to be the most likely candidate. However,
more recently the same group could show that the ATP-
induced potentiation can also be observed in dorsal root
ganglion neurons of P2Y1-deficient mice [126]. Moreover,
in in situ hybridizations rat dorsal root ganglion neurons
were found to co-express VR1 and P2Y2 mRNA, but not
P2Y1 mRNA. UTP was reported to be as potent an agonist
as ATP, and suramin (which blocks P2Y2 but not P2Y4)
abolished the potentiation by UTP. Taken together, these
results indicated that it was rather the P2Y2 than the P2Y1
receptor that mediated the effects of nucleotides on VR1 in
mouse and rat DRG neurons.
Recombinant receptors
In addition to the above effects obtained with native P2Y
receptors in primary neuronal cell cultures, akin results
were also obtained when P2Y receptors were heterolo-
gously expressed in Xenopus oocytes. When co-expressed
together with the P2X1 receptor, activation of both, P2Y1
and P2Y2, caused a significant potentiation of the
a,b-MeATP-induced current through P2X1 [127].
Functional consequences of neuronal ion channel
regulation via P2Y receptors
The effects of P2Y receptor activation on neuronal ion
channels that have been observed most consistently and
frequently are (1) inhibition of voltage-activated Ca
2+
currents, (2) activation of Ca
2+-dependent K
+ channels or
GIRKs, and (3) inhibition of IM. Voltage-gated Ca
2+
channels, in particular N- and P/Q-type channels, are
located at presynaptic nerve terminals and link invading
action potentials to transmembrane Ca
2+ influx and ensuing
vesicle exocytosis. Accordingly, the modulation of these
ion channels via G protein-coupled receptors will lead to
changes in transmitter release [128]. The kinetics of
presynaptic action potentials are shaped by voltage-
activated and Ca
2+-dependent K
+ channels, and modulation
of these channels via G protein-coupled receptors can also
lead to changes in vesicle exocytosis [129, 130]. In contrast
to these K
+ channels, inwardly rectifying K
+ channels
including GIRKs are hardly found at presynaptic nerve
terminals and are generally not believed to directly
contribute to transmitter release [129, 131]. With respect
to KCNQ channels, which mediate IM, contrasting results
have been obtained. In peripheral sympathetic neurons, no
evidence could be obtained for a role of these ion channels
in presynaptic transmitter release [132, 133]. However, in
central synaptosomes, modulators of these ion channels
were found to affect the release of various transmitters
[134]. Hence, the regulation of Ca
2+ channels and Ca
2+-
dependent K
+ channels via P2Y receptors will preferen-
tially lead to changes in synaptic transmission via a
presynaptic modulation of transmitter release, whereas the
control of GIRKs and KCNQ channels will rather cause
changes in the postsynaptic excitability. The modulation of
ligand-gated ion channels may lead to pre- as well as
36 S.G. Lechner & S. Boehmpostsynaptic effects depending on where the regulated
ionotropic receptors are located [135]. In fact, ATP and
other nucleotides acting at P2Y receptors may cause both,
pre- and postsynaptic effects in the central as well as
peripheral nervous system.
In the cortex and hippocampus, nucleotides were found
to inhibit the release of acetylcholine and noradrenaline
via presynaptic sites of action. With respect to the
release of dopamine, serotonin and glutamate, inhibitory
as well as facilitatory presynaptic effects have been
described for nucleotides in a variety of brain regions.
The release of the inhibitory transmitters GABA and
glycine, however, is rather enhanced than reduced by
nucleotides. The precise receptor subtypes involved in
these presynaptic effects remained mostly unknown, and
only the facilitatory effects were evidenced to be
mediated by P2X receptors. Moreover, a clear-cut role
of presynaptic Ca
2+ or K
+ channels in the modulatory
effects of nucleotides was not established, as reviewed by
Cunha and Ribeiro [136]. In hippocampal neurons, a
presynaptic P2Y receptor mediated an ATP-dependent
inhibition of excitatory, but not of inhibitory, synaptic
transmission via PTX-sensitive G proteins, and an inhibi-
tion of voltage-activated Ca
2+ currents. However, the
receptor subtype(s) involved were not further characterized
[137]. In the medial habenula, a presynaptic P2Y4-like
receptor was shown to enhance glutamate release, whereas
a presumed P2Y2-like receptor mediated an inhibition
[138]. Whether these presynaptic P2Y receptors affected
transmitter release through a modulation of Ca
2+ or K
+
channels remained unfortunately unknown. In the prefron-
tal and parietal cortex, activation of a P2Y1-like receptor
reduced glutamatergic transmission, but only the compo-
nent involving NMDA receptors. Furthermore, the receptor
mediated an inhibition of depolarizations caused by N-methyl-
D-aspartate, but not of those induced by alpha-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid [123]. Thus,
P2Y receptor activation may also interfere with synaptic
transmission via a modulation of postsynaptic ionotropic
receptors.
In the periphery, in autonomic and motor neurons,
release of acteylcholine or noradrenaline was also
reported to be controlled by presynaptic P2X and P2Y
receptors [136]. The system that has been studied in
greatest detail is the sympathetic nervous system, since
ATP and noradrenaline have long been known as cotrans-
mitters there. Early evidence for presynaptic nucleotide
receptors in sympathetic neurons has been obtained 20 years
ago [139]. More recently, several nucleotides were found
to reduce, whereas P2 receptor antagonists were found to
enhance, noradrenaline release from the mouse vas
deferens as indication of inhibitory presynaptic P2Y
autoreceptors [140]. In numerous other sympathetically
innervated tissues, nucleotides were also reported to inhibit
transmitter release [141, 142]. For a long period of time,
the P2Y receptor subtypes involved in these effects
remained unknown, but recent evidence suggests that
P2Y12 and/or P2Y13 receptors mediate autoinhibition of
transmitter release from sympathetic neurons [143]. In
PC12 cells which are ontogenetically related to sympathet-
ic neurons, P2Y12 receptors mediate an inhibition of
voltage-activated Ca
2+ channels (see above and [91–93]).
Most recently, this effect was also observed in primary
cultures of rat superior cervical ganglion neurons and it
was demonstrated to mediate autoinhibition of transmitter
release [96]. Hence, sympatho-effector transmission is
regulated by an inhibition of voltage-activated Ca
2+
channels via presynaptic P2Y12 receptors. In sensory
neurons, in contrast, P2Y1 receptors mediate an inhibition
of voltage-activated Ca
2+ channels [144], and this effect
apparently leads to reduced synaptic transmission in pain
pathways and to analgesic effects [95].
However, P2Y receptor activation mediates not only
inhibitory, but also excitatory effects in sensory neurons.
P2Y1 receptor activation, in particular, was suggested to
facilitate touch-induced impulse generation in sensory
neurons [145], but the underlying mechanisms remained
unknown. In this context, the interaction with VR1
receptors might be a relevant mechanism (see above). In
autonomic neurons, P2Y1 receptors were also involved in
excitatory postsynaptic effects: Excitatory postsynaptic
potentials that were blocked by a P2Y1 receptor antagonist
were observed in the enteric nervous system. Direct
activation of these receptors caused a Na
+-dependent
increase in membrane conductance, but the precise ionic
mechanisms were not further investigated [146]. In
postganglionic sympathetic neurons, P2Y receptors were
also found to mediate excitatory postsynaptic effects. UTP
depolarizes sympathetic ganglia and triggers transmitter
release from dissociated sympathetic neurons via receptors
different from those activated by ATP [147, 148]. The
secretagogue action of UTP was mimicked equipotently by
UDP [111, 148], and both nucleotides also caused an
inhibition of IM [109, 111]. The receptor involved was
evidenced to be P2Y6. However, the stimulatory effect did
not only involve the inhibition of KCNQ channels, but also
an activation of protein kinase C [149].
Conclusion
The modulation of neuronal ion channels via G protein-
coupled receptors is a major means of adapting the
responsiveness of a neuron to changes in environmental
conditions [1]. Such modulatory effects have been de-
scribed for virtually all known neurotransmitters and
nucleotides are no exception. Within the last 15 years,
8 different G protein-coupled nucleotide receptors have
been characterized, and numerous examples of ion chan-
nels that are regulated via one or more of these receptors
are described here. Thus, aside of their functions as fast
synaptic transmitters acting at P2X receptors [150],
nucleotides also fulfil roles as neuromodulators, as do
many other classical transmitter, such as glutamate, GABA,
acetylcholine, and serotonin. Thus, this summary of ion
channels regulated via P2Y receptors adds ATP and related
nucleotides to this list of pluripotent neurotransmitters.
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